Articles

  Study subjects who had the hepatitis B vaccination had an 81% reduction in diabetes risk….

African Americans with type 2 diabetes respond better to metformin’s glucose lowering effects….

When Steve and Andrew got back from the ADA’s 74th Scientific Sessions in San Francisco, we put together an awesome overview of some of the new research and studies on GLP-1. Now that we have had some time to review the entire program we are providing you with more of …

There was a lot of great information at this year’s ADA Scientific Sessions on the sodium glucose co-transporter 2 (SGLT2) inhibitors both alone and in combination with other medications, and we have a review for you. Canagliflozin  Canagliflozin has demonstrated improvement in glycemic control, body weight, and blood pressure across …

Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …

An automated "bionic" pancreas that incorporates glucagon as well as insulin has shown improved blood glucose for five consecutive days in a study of patients with type 1 diabetes….

Some diabetes experts have expressed concerns about recent national guidelines on lipid management, criticizing a lack of LDL cholesterol targets and little direction for management with drugs beyond statins…. 

Even if the FDA approves Technosphere Insulin Inhalation Powder (TI) in the US, will it get recommended?…

Depression has been linked with worse survival in a 20-year observational study of patients with type 1 diabetes…. 

Diabetes patients stand to benefit from two experimental insulin therapies that could eventually replace Sanofi’s global leader Lantus, according to results from large clinical trials….  Both treatments are basal insulins, which help diabetics keep blood sugar levels under control between meals and throughout the day. Sanofi’s experimental new drug Toujeo …